Cell surface blood group antigens in prostatic carcinoma

Area of Science:

• Oncology
• Immunology
• Pathology

Background:

• Surface blood group antigens are typically present in most epithelia.
• Neoplastic transformation often leads to the loss of these antigens.
• Understanding antigen expression in cancer is crucial for diagnosis and treatment.

Purpose of the Study:

• To investigate the presence or absence of surface blood group antigens in prostatic carcinoma.
• To correlate antigen expression with histologic grade and blood type in prostate cancer.

Main Methods:

• Utilized the specific red blood cell adherence test.
• Analyzed 52 cases of prostatic carcinoma with varying histologic grades.
• Examined normal prostatic tissue, hyperplastic areas, and malignant foci.

Main Results:

• Normal prostatic tissue showed varying antigen expression based on blood type (A/B vs. O).
• Hyperplastic prostatic tissue demonstrated strong antigen adherence, particularly in blood types A or B.
• All malignant foci of prostate cancer were negative for blood group antigens, irrespective of histologic grade or patient blood type.

Conclusions:

• Loss of surface blood group antigens is a consistent feature of prostatic carcinoma.
• This antigen loss occurs independently of cancer grade or individual blood type.
• Blood group antigen status may serve as a biomarker in prostate cancer research.